Cargando…
Development of a New Vaccine for the Prevention of Lassa Fever
BACKGROUND: Recent importation of Lassa fever into Germany, the Netherlands, the United Kingdom, and the United States by travelers on commercial airlines from Africa underscores the public health challenge of emerging viruses. Currently, there are no licensed vaccines for Lassa fever, and no experi...
Autores principales: | Geisbert, Thomas W, Jones, Steven, Fritz, Elizabeth A, Shurtleff, Amy C, Geisbert, Joan B, Liebscher, Ryan, Grolla, Allen, Ströher, Ute, Fernando, Lisa, Daddario, Kathleen M, Guttieri, Mary C, Mothé, Bianca R, Larsen, Tom, Hensley, Lisa E, Jahrling, Peter B, Feldmann, Heinz |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1160587/ https://www.ncbi.nlm.nih.gov/pubmed/15971954 http://dx.doi.org/10.1371/journal.pmed.0020183 |
Ejemplares similares
-
Pathogenesis of lassa fever in cynomolgus macaques
por: Hensley, Lisa E, et al.
Publicado: (2011) -
Effective Post-Exposure Treatment of Ebola Infection
por: Feldmann, Heinz, et al.
Publicado: (2007) -
Postexposure Treatment of Marburg Virus Infection
por: Geisbert, Thomas W., et al.
Publicado: (2010) -
Vesicular Stomatitis Virus-Based Ebola Vaccine Is Well-Tolerated and Protects Immunocompromised Nonhuman Primates
por: Geisbert, Thomas W., et al.
Publicado: (2008) -
A Recombinant Vesicular Stomatitis Virus-Based Lassa Fever Vaccine Protects Guinea Pigs and Macaques against Challenge with Geographically and Genetically Distinct Lassa Viruses
por: Safronetz, David, et al.
Publicado: (2015)